LumiraDx to sell point of care technology platform to Roche for $295M

Diagnostics company LumiraDx announced it signed an agreement to sell its point-of-care technology to pharma giant Roche for $295 million, with an additional payment of $55 million to fund the platform until the acquisition closes.  LumiraDx developed a diagnostic testing system that uses a small, portable instrument and microfluidic test strips to perform multiple lab-quality … Read more

Medicare Advantage insurtech company Devoted Health secures $175M

Tech-enabled Medicare Advantage company Devoted Health announced it scored $175 million in Series E funding at the end of 2023. Venture capital companies Fearless Ventures, Highbury Holdings, Stardust Equity, GIC, Maverick Ventures and The Space Between led the round. Andreessen Horowitz, Emerson Collective, Socium Ventures, The Private Shares Fund, and affiliated funds, General Catalyst, F-Prime … Read more

New Safety Concerns About the COVID Shots Arise

According to research published in the December 6, 2023, issue of Nature, the mRNA COVID shots suffer from high rates of ribosomal “frameshifting,” which causes your cells to produce off-target proteins with unknown effects.1,2,3 As explained in that paper:4 “A key feature of therapeutic IVT [in vitro-transcribed] mRNAs is that they contain modified ribonucleotides, which … Read more